DEF 14AThe Ballot
Acrivon Therapeutics, Inc. files DEF 14A
Filed Apr 25, 2025 · 1y ago · Accession 0000950170-25-058352
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Acrivon Therapeutics, Inc.
- Ticker
- ACRV
- CIK
- 1781174
- Form type
- DEF 14A
- Filing date
- Apr 25, 2025
- Report date
- Jun 13, 2025
- Document
- acrv-20250424.htm
- Size
- 5.1 MB